Gene · 9020
Papers3,446
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,446
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inhibition of Cancer Development by Natural Plant Polyphenols: Molecular Mechanisms. | Int J Mol Sci | 2023 | 37445850 | PubTator, text mining | PubMed |
| Spermidine Attenuates High Glucose-Induced Oxidative Damage in Retinal Pigment Epithelial Cells by Inhibiting Production of ROS and NF-κB/NLRP3 Inflammasome Pathway. | Int J Mol Sci | 2023 | 37445726 | PubTator, text mining | PubMed |
| The Evolutionary Scenario of Pediatric Unclassified Primary Antibody Deficiency to Adulthood. | J Clin Med | 2023 | 37445241 | PubTator, text mining | PubMed |
| An HBV susceptibility variant of KNG1 modulates the therapeutic effects of interferons α and λ1 in HBV infection by promoting MAVS lysosomal degradation. | EBioMedicine | 2023 | 37442062 | PubTator, text mining | PubMed |
| Pan-cancer analysis of the prognostic and immunological role of GJB2: a potential target for survival and immunotherapy. | Front Oncol | 2023 | 37427102 | PubTator, text mining | PubMed |
| Characterization of tumor-associated reactive astrocytes in gliomas by single-cell and bulk tumor sequencing. | Front Neurol | 2023 | 37416308 | PubTator, text mining | PubMed |
| Insights into the role of HIV-1 Vpu in modulation of NF-ĸB signaling pathways. | mBio | 2023 | 37409832 | PubTator, text mining | PubMed |
| The key piece of the airway remodeling puzzle revealed-LIGHT signaling in the lung. | Genes Dis | 2023 | 37397546 | PubTator, text mining | PubMed |
| DEAD-box RNA helicases with special reference to p68: Unwinding their biology, versatility, and therapeutic opportunity in cancer. | Genes Dis | 2023 | 37397539 | PubTator, text mining | PubMed |
| Modulation of SIRT6 activity acts as an emerging therapeutic implication for pathological disorders in the skeletal system. | Genes Dis | 2023 | 37396554 | PubTator, text mining | PubMed |
| Regulation of IFNβ expression: focusing on the role of its promoter and transcription regulators. | Front Microbiol | 2023 | 37396372 | PubTator, text mining | PubMed |
| Crosstalk between autophagy and bladder transitional cell carcinoma by autophagy-related lncRNAs. | Medicine (Baltimore) | 2023 | 37390250 | PubTator, text mining | PubMed |
| Clinical relevance of molecular aspects in extranodal marginal zone lymphoma: a critical appraisal. | Ther Adv Med Oncol | 2023 | 37389189 | PubTator, text mining | PubMed |
| Prevention of atrial fibrillation after open-chest surgery with extracellular vesicle therapy. | JCI Insight | 2023 | 37384420 | PubTator, text mining | PubMed |
| Pharmacological Approaches to Modulate the Scarring Process after Glaucoma Surgery. | Pharmaceuticals (Basel) | 2023 | 37375845 | PubTator, text mining | PubMed |
| NF-κB in Cell Deaths, Therapeutic Resistance and Nanotherapy of Tumors: Recent Advances. | Pharmaceuticals (Basel) | 2023 | 37375731 | PubTator, text mining | PubMed |
| The Recent Research Progress of NF-κB Signaling on the Proliferation, Migration, Invasion, Immune Escape and Drug Resistance of Glioblastoma. | Int J Mol Sci | 2023 | 37373484 | PubTator, text mining | PubMed |
| Classical Hodgkin Lymphoma: From Past to Future-A Comprehensive Review of Pathophysiology and Therapeutic Advances. | Int J Mol Sci | 2023 | 37373245 | PubTator, text mining | PubMed |
| Identification and Interpretation of eQTL and eGenes for Hodgkin Lymphoma Susceptibility. | Genes (Basel) | 2023 | 37372322 | PubTator, text mining | PubMed |
| Pathogenesis, Intervention, and Current Status of Drug Development for Sarcopenia: A Review. | Biomedicines | 2023 | 37371730 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9020/papers?page=14